Abstract: The present invention relates to a bifunctional peptide comprising a virus binding moiety (2) and a mucin binding moiety (1) covalently bound to the virus binding moiety (2). The virus binding moiety is chosen from peptides binding to SARS-CoV-2, to influenza A, to influenza B, to rhinoviruses and other enteroviruses, to human parainfluenza virus, and/or to metapneuvirus. The mucin binding moiety is chosen from lectins such as trefoil factor 3.
| # | Name | Date |
|---|---|---|
| 1 | 202427083596-Sequence Listing in XML (WIPO ST26) [31-10-2024(online)].pdf | 2024-10-31 |
| 2 | 202427083596-Sequence Listing in PDF [31-10-2024(online)].pdf | 2024-10-31 |
| 3 | 202427083596-REQUEST FOR EXAMINATION (FORM-18) [31-10-2024(online)].pdf | 2024-10-31 |
| 4 | 202427083596-PRIORITY DOCUMENTS [31-10-2024(online)].pdf | 2024-10-31 |
| 5 | 202427083596-FORM 18 [31-10-2024(online)].pdf | 2024-10-31 |
| 6 | 202427083596-FORM 1 [31-10-2024(online)].pdf | 2024-10-31 |
| 7 | 202427083596-FIGURE OF ABSTRACT [31-10-2024(online)].pdf | 2024-10-31 |
| 8 | 202427083596-DRAWINGS [31-10-2024(online)].pdf | 2024-10-31 |
| 9 | 202427083596-DECLARATION OF INVENTORSHIP (FORM 5) [31-10-2024(online)].pdf | 2024-10-31 |
| 10 | 202427083596-COMPLETE SPECIFICATION [31-10-2024(online)].pdf | 2024-10-31 |
| 11 | 202427083596-Proof of Right [22-11-2024(online)].pdf | 2024-11-22 |
| 12 | 202427083596-FORM-26 [22-11-2024(online)].pdf | 2024-11-22 |
| 13 | Abstract1.jpg | 2024-12-02 |
| 14 | 202427083596-FORM 3 [16-04-2025(online)].pdf | 2025-04-16 |
| 15 | 202427083596-Response to office action [10-07-2025(online)].pdf | 2025-07-10 |